• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由聚乳酸-乙醇酸共聚物-聚乙二醇嵌段共聚物和聚乳酸-乙醇酸共聚物/聚乳酸-乙醇酸共聚物-聚乙二醇共混物制备的可注射植入物的溶菌酶释放和聚合物侵蚀行为

Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends.

作者信息

Vesna Milacic Vesna Milacic, Schwendeman Steven P

出版信息

Pharm Res. 2014 Feb;31(2):436-48. doi: 10.1007/s11095-013-1173-6.

DOI:10.1007/s11095-013-1173-6
PMID:23959854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3930621/
Abstract

PURPOSE

We evaluated the controlled release of lysozyme from various poly(D,L-lactic-co-glycolic acid) (PLGA) 50/50-polyethylene glycol (PEG) block copolymers relative to PLGA 50/50.

METHODS

Lysozyme was encapsulated in cylindrical implants (0.8 mm diameter) by a solvent extrusion method. Release studies were conducted in phosphate buffered saline +0.02% Tween 80 (PBST) at 37°C. Lysozyme activity was measured by a fluorescence-based assay. Implant erosion was evaluated by kinetics of polymer molecular weight decline, water uptake, and mass loss.

RESULTS

Lysozyme release from an AB15 di-block copolymer (15% 5 kDa PEG, PLGA 28 kDa) was very fast, whereas an AB10 di-block copolymer (with 10% 5 kDa PEG, PLGA 45 kDa) and ABA10 tri-block copolymer (with 10% 6 kDa PEG, PLGA 27 kDa) showed release profiles similar to PLGA. We achieved continuous lysozyme release for up to 4 weeks from AB10 and ABA10 by lysozyme co-encapsulation with the pore-forming and acid-neutralizing MgCO3, and from AB15 by co-encapsulation of MgCO3 and blending AB15 with PLGA. Lysozyme activity was mostly recovered during 4 weeks.

CONCLUSIONS

These block co-polymers may have utility either alone or as PLGA blends for the controlled release of proteins.

摘要

目的

我们评估了相对于聚(D,L-乳酸-乙醇酸共聚物)(PLGA)50/50,溶菌酶从各种PLGA 50/50-聚乙二醇(PEG)嵌段共聚物中的控释情况。

方法

通过溶剂挤出法将溶菌酶封装在圆柱形植入物(直径0.8毫米)中。在37°C的磷酸盐缓冲盐水+0.02%吐温80(PBST)中进行释放研究。通过基于荧光的测定法测量溶菌酶活性。通过聚合物分子量下降、吸水率和质量损失的动力学来评估植入物的侵蚀情况。

结果

从AB15二嵌段共聚物(15% 5 kDa PEG,PLGA 28 kDa)中释放溶菌酶非常快,而AB10二嵌段共聚物(含10% 5 kDa PEG,PLGA 45 kDa)和ABA10三嵌段共聚物(含10% 6 kDa PEG,PLGA 27 kDa)显示出与PLGA相似的释放曲线。通过将溶菌酶与成孔和中和酸的MgCO3共封装,我们从AB10和ABA10中实现了长达4周的持续溶菌酶释放,通过MgCO3共封装并将AB15与PLGA混合,从AB15中实现了持续释放。溶菌酶活性在4周内大部分得以恢复。

结论

这些嵌段共聚物单独使用或作为PLGA共混物用于蛋白质的控释可能具有实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/68e4d2945f7c/nihms517211f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/36d0e034b3aa/nihms517211f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/287df288ca9d/nihms517211f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/ab9186d4e8d1/nihms517211f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/91dd68e78118/nihms517211f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/3a7437f1e527/nihms517211f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/68e4d2945f7c/nihms517211f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/36d0e034b3aa/nihms517211f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/287df288ca9d/nihms517211f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/ab9186d4e8d1/nihms517211f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/91dd68e78118/nihms517211f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/3a7437f1e527/nihms517211f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb2/3930621/68e4d2945f7c/nihms517211f6.jpg

相似文献

1
Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends.由聚乳酸-乙醇酸共聚物-聚乙二醇嵌段共聚物和聚乳酸-乙醇酸共聚物/聚乳酸-乙醇酸共聚物-聚乙二醇共混物制备的可注射植入物的溶菌酶释放和聚合物侵蚀行为
Pharm Res. 2014 Feb;31(2):436-48. doi: 10.1007/s11095-013-1173-6.
2
Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.制剂参数对注射用圆柱形聚(DL-丙交酯-乙交酯)植入物中2-甲氧基雌二醇释放的影响。
Eur J Pharm Biopharm. 2008 Sep;70(1):187-98. doi: 10.1016/j.ejpb.2008.03.007. Epub 2008 Mar 20.
3
PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.替瑞利克斯的聚乳酸-羟基乙酸共聚物-聚乙二醇微球:聚合物类型对微球特性及替瑞利克斯体外释放的影响
Int J Pharm. 2003 Aug 11;261(1-2):69-80. doi: 10.1016/s0378-5173(03)00272-2.
4
Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.包封有不同释放特性和隐身性的磷酸倍他米松的聚合物纳米颗粒。
Int J Pharm. 2009 Jun 22;375(1-2):148-54. doi: 10.1016/j.ijpharm.2009.04.001. Epub 2009 Apr 10.
5
Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.不同添加剂和聚合物对通过 s/o/w 乳液技术制备的 PLGA 微球中溶菌酶释放的影响。
Eur J Pharm Biopharm. 2010 Jun;75(2):128-36. doi: 10.1016/j.ejpb.2010.03.005. Epub 2010 Mar 11.
6
Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.聚乳酸-羟基乙酸共聚物微球中与聚乙二醇-聚(L-组氨酸)二嵌段共聚物复合的牛血清白蛋白的稳定性
J Control Release. 2005 Dec 5;109(1-3):86-100. doi: 10.1016/j.jconrel.2005.09.016. Epub 2005 Nov 2.
7
The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.由聚乳酸-乙醇酸共聚物(PLGA)与低分子量二嵌段共聚物的共混物制备的载紫杉醇微球的表征
Int J Pharm. 2007 Sep 5;342(1-2):6-17. doi: 10.1016/j.ijpharm.2007.04.022. Epub 2007 May 3.
8
Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.用低分子聚乙二醇对可生物降解的聚(苹果酸)和聚(乳酸-乙醇酸共聚物)微粒进行改性。
Drug Dev Ind Pharm. 2009 Apr;35(4):449-54. doi: 10.1080/03639040802438357.
9
Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering.用于组织工程中大尺寸 PLGA 微球中蛋白质释放调节的配方。
Mater Sci Eng C Mater Biol Appl. 2015 Feb;47:230-6. doi: 10.1016/j.msec.2014.11.003. Epub 2014 Nov 7.
10
Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.溶菌酶包封的聚(D,L-丙交酯-共-乙交酯)微球的蛋白质释放动力学、稳定性及蛋白质-聚合物相互作用评估
J Control Release. 2002 Feb 19;79(1-3):137-45. doi: 10.1016/s0168-3659(01)00533-8.

引用本文的文献

1
PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential.用于药物控释和再生医学的聚乳酸-羟基乙酸共聚物植入物:进展、挑战与临床潜力
Pharmaceuticals (Basel). 2025 Apr 27;18(5):631. doi: 10.3390/ph18050631.
2
A review on the promising antibacterial agents in bone cement-From past to current insights.关于骨水泥中具有前景的抗菌剂的综述——从过去到现在的见解。
J Orthop Surg Res. 2024 Oct 20;19(1):673. doi: 10.1186/s13018-024-05143-7.
3
Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits.

本文引用的文献

1
Stabilization of tetanus toxoid encapsulated in PLGA microspheres.包裹于聚乳酸-羟基乙酸共聚物微球中的破伤风类毒素的稳定性
Mol Pharm. 2008 Sep-Oct;5(5):808-17. doi: 10.1021/mp800027f. Epub 2008 Aug 19.
2
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.将疏水性药物包裹于聚乳酸/聚乳酸-羟基乙酸共聚物微粒中的原理。
Int J Pharm. 2008 Dec 8;364(2):298-327. doi: 10.1016/j.ijpharm.2008.04.042. Epub 2008 May 7.
3
Moisture-induced aggregation of lyophilized proteins in the solid state.固态下冻干蛋白质的水致聚集。
基于聚乳酸-羟基乙酸共聚物(PLGA)和聚乳酸-羟基乙酸共聚物-聚乙二醇-聚乳酸-羟基乙酸共聚物(PLGA-PEG-PLGA)的用于利培酮缓释的可注射原位形成长效注射剂:体外评价及兔体内药代动力学研究
Pharmaceutics. 2023 Apr 13;15(4):1229. doi: 10.3390/pharmaceutics15041229.
4
Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer.微粒包封前列腺靶向生物制剂用于治疗去势抵抗性前列腺癌临床前模型中的肝转移。
Mol Cancer Ther. 2020 Nov;19(11):2353-2362. doi: 10.1158/1535-7163.MCT-20-0227. Epub 2020 Sep 17.
5
Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres.溶菌酶从双层聚(丙交酯-共-乙交酯)(PLGA)微球中的控释。
Polymers (Basel). 2017 Oct 3;9(10):485. doi: 10.3390/polym9100485.
6
Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ plaques in Alzheimer's disease.表面工程化的 PLGA 纳米颗粒给药系统的研制,用于递送 Tet1 偶联纳豆激酶酶抑制阿尔茨海默病中的 Aβ 斑块。
Int J Nanomedicine. 2017 Dec 13;12:8749-8768. doi: 10.2147/IJN.S144545. eCollection 2017.
7
Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species.小鼠巨噬细胞对有毒和无毒伯克霍尔德菌属感染反应的特征分析
BMC Microbiol. 2015 Nov 6;15:259. doi: 10.1186/s12866-015-0593-3.
Biotechnol Bioeng. 1991 Jan 20;37(2):177-84. doi: 10.1002/bit.260370210.
4
Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.制剂参数对注射用圆柱形聚(DL-丙交酯-乙交酯)植入物中2-甲氧基雌二醇释放的影响。
Eur J Pharm Biopharm. 2008 Sep;70(1):187-98. doi: 10.1016/j.ejpb.2008.03.007. Epub 2008 Mar 20.
5
Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.用pH修饰的重组人碱性成纤维细胞生长因子/聚(DL-乳酸-共-乙醇酸)植入物挽救重症联合免疫缺陷小鼠的缺血后肢
J Control Release. 2007 Oct 8;122(3):331-7. doi: 10.1016/j.jconrel.2007.05.016. Epub 2007 May 23.
6
Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins.可生物降解聚合物中的孔隙闭合与开放及其对蛋白质控释的影响。
Mol Pharm. 2007 Jan-Feb;4(1):104-18. doi: 10.1021/mp060041n.
7
Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.可注射聚合物微球增强避孕肽疫苗的免疫原性。
Vaccine. 2007 Jan 5;25(3):500-9. doi: 10.1016/j.vaccine.2006.07.055. Epub 2006 Aug 17.
8
Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles.载醋酸亮丙瑞林的聚(丙交酯-乙交酯)微粒三相药物释放模式的修饰
Eur J Pharm Biopharm. 2006 Jun;63(2):205-14. doi: 10.1016/j.ejpb.2005.12.010. Epub 2006 Apr 18.
9
Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.聚乳酸-乙醇酸共聚物薄膜中微气候pH值的预测
J Am Chem Soc. 2006 Apr 26;128(16):5384-90. doi: 10.1021/ja055287k.
10
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.用于疫苗抗原注射递送的可生物降解聚(乳酸-乙醇酸)微颗粒。
Adv Drug Deliv Rev. 2005 Jan 10;57(3):391-410. doi: 10.1016/j.addr.2004.09.003.